Putting brakes on insulin pump infusion to prevent hypoglycemia.
The author provides an analysis of the study published by Agrawal and colleagues, in this issue of Journal of Diabetes Science and Technology, which describes usage and effectiveness of the low glucose suspend feature that is integrated into the Medtronic Paradigm® Veo™ sensor-augmented pump system.
Yale Pediatric Endocrinology, New Haven, Connecticut 06519, USA. Eda.Cengiz@yale.edu
Eda
E
Cengiz
D001786:Blood Glucose / Q000032:analysis*; D015190:Blood Glucose Self-Monitoring; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D007328:Insulin / Q000008:administration & dosage*; D007332:Insulin Infusion Systems; D008297:Male
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin